Thorax · 2020 · 11 citations · 5 references
MedicineCell BiologyOncologyNeoplasiaOncogenesTranslational OncologyAnimal Cell CultureCancer Stem Cell BiologyCancer Stem CellsCellular TherapyMalignant NeoplasmsStem Cell TumorigenicityCancer Cell Culture ModelsCancer Stem Cell ModelsCancer Stem-like CellsEx Vivo ModelsMalignant Pleural Mesothelioma ImmunotherapyNeoantigen-specific T CellsStemness AcquisitionStemness Heterogeneity
Malignant pleural mesothelioma (MPM) is an aggressive cancer, associated with poor prognosis. We assessed the feasibility of patient-derived cell cultures to serve as an ex vivo model of MPM. Patient-derived MPM cell cultures (n=16) exhibited stemness features and reflected intratumour and interpatient heterogeneity. A subset of the cells were subjected to high-throughput drug screening and coculture assays with cancer-specific cytotoxic T cells and showed diverse responses. Some of the biphasic MPM cells were capable of processing and presenting the neoantigen SSX-2 endogenously. In conclusion, patient-derived MPM cell cultures are a promising and faithful ex vivo model of MPM.
5
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Julija Hmeljak, Francisco Sánchez-Vega, Katherine A. Hoadley et al. · Cancer Discovery · 2018 · 618 citations · Full text
Ian Woolhouse, Lesley Bishop, Liz Darlison et al. · Thorax · 2018 · 219 citations · Full text
Establishment of human malignant mesothelioma cell lines
Marjan A. Versnel, M.J. Bouts, Henk C. Hoogsteden et al. · International Journal of Cancer · 1989 · 51 citations